Aquestive Therapeutics (AQST) PT Raised to $13 at Leerink Partners
Tweet Send to a Friend
Leerink Partners analyst Roanna Ruiz raised the price target on Aquestive Therapeutics (NASDAQ: AQST) to $13.00 (from $12.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
